A systematic study on pharmacokinetcs and tissue distribution of danshensu (one of the
major active components from Salvia miltiorrhiza) is conducted using a rapid and sensitive …

To determine Danshensu in urine and study its pharmacokinetics in human. A solid phase
extraction-HPLC method was used for determination of Danshensu in urine of human. HPLC …

A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed
and validated for the determination and pharmacokinetics of danshensu in rat plasma …

A sensitive and specific HPLC‐UV method was developed for the simultaneous
determination of major active components of danshen in rat plasma. Both water‐soluble and …

Danshensu, as the effective component of Salvia miltiorrhiza (Danshen), has been widely
used in clinical studies for treatment of cardiovascular diseases in China. A new metabolite …

In our research, ultraperformance liquid chromatography/quadrupole-time-of-flight mass
spectrometry (U-HPLC/Q-TOF-MS) was established for analyzing the metabolite profiles of …

A simple and sensitive high performance liquid chromatography method has been
developed for the determination of Danshensu (3, 4‐dihydroxyphenyllactic acid) in dog …

A novel method, using high‐performance liquid chromatography combined with principal
component analysis, was developed for the quality evaluation of danshen through …

Objective To develop a HPLC method for determination of the concentration of Danshensu
in rat plasma and undertake comparative pharmacokinetic study of sodium danshensu and …

Aim: To study the pharmacokinetic effects of salvianolic acid B (Sal B) on danshensu (DSS)
in Danshen injection in rats. Method: Following the intravenous administration of Danshen …